http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101940417-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101940417-B1 |
| titleOfInvention | A Screening Method of a Substance for Preventing or Treating a X-linked Adrenoleukodystrophy |
| abstract | The present invention relates to a method for screening substances for the prevention or treatment of X-linked adrenoleukodystrophy through evaluation of inhibition of cholesterol 25-hydroxylase (CH25H) and / or 25-hydroxycholesterol (25-HC) To a novel pharmaceutical composition for the prevention or treatment of leukodystrophy. When the method for screening a candidate drug for prophylaxis or treatment of adrenoleukodystrophy of the present invention is used, it is possible to provide an effective platform for developing a therapeutic agent for adrenoleukodystrophy, and to derive a drug candidate more effectively. In addition, when the pharmaceutical composition of the present invention is used, adrenal dysentery can be more effectively treated. |
| priorityDate | 2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 966.